A citation-based method for searching scientific literature

Achim Rittmeyer, Fabrice Barlesi, Daniel Waterkamp, Keunchil Park, Fortunato Ciardiello, Joachim von Pawel, Shirish M Gadgeel, Toyoaki Hida, Dariusz M Kowalski, Manuel Cobo Dols, Diego L Cortinovis, Joseph Leach, Jonathan Polikoff, Carlos Barrios, Fairooz Kabbinavar, Osvaldo Arén Frontera, Filippo De Marinis, Hande Turna, Jong-Seok Lee, Marcus Ballinger, Marcin Kowanetz, Pei He, Daniel S Chen, Alan Sandler, David R Gandara. Lancet 2017
Times Cited: 2364



Daniel S Chen, Ira Mellman. Immunity 2013
Times Cited: 2414




List of shared articles



Times cited

Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms.
Mu-Yang Huang, Xiao-Ming Jiang, Bing-Lin Wang, Yang Sun, Jin-Jian Lu. Pharmacol Ther 2021
5

Circulating leukocyte-platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced non-small cell lung cancer patients receiving anti-PD-(L)1 blocking agents.
Carlos Zamora, Mariona Riudavets, Georgia Anguera, Letícia Alserawan, Ivana Sullivan, Andrés Barba, Jorgina Serra, M Angels Ortiz, Pablo Gallardo, Lidia Perea,[...]. Cancer Immunol Immunother 2021
2

Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients.
Ja Yoon Heo, Shin Hye Yoo, Koung Jin Suh, Se Hyun Kim, Yu Jung Kim, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim,[...]. Sci Rep 2021
0

Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC.
Mengke Niu, Ming Yi, Ning Li, Suxia Luo, Kongming Wu. Exp Hematol Oncol 2021
6

Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade.
Romain Banchereau, Avantika S Chitre, Alexis Scherl, Thomas D Wu, Namrata S Patil, Patricia de Almeida, Edward E Kadel Iii, Shravan Madireddi, Amelia Au-Yeung, Chikara Takahashi,[...]. J Immunother Cancer 2021
2




Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies.
Kenneth K W To, Winnie Fong, William C S Cho. Front Oncol 2021
5

Elevated expression of B7 homolog 4 is associated with disease progression in upper urinary tract urothelial carcinoma.
Tomoya Mizuno, Takao Kamai, Toyonori Tsuzuki, Daisaku Nishihara, Toshiki Kijima, Kyoko Arai, Ken-Ichiro Yoshida. Cancer Immunol Immunother 2021
1

Determining PD-L1 Status in Patients with Triple-Negative Breast Cancer: Lessons Learned from IMpassion130.
Sunil S Badve, Frédérique Penault-Llorca, Jorge S Reis-Filho, Regula Deurloo, Kalliopi P Siziopikou, Corrado D'Arrigo, Giuseppe Viale. J Natl Cancer Inst 2021
0